European regulators approve diabetes drug by Lilly, Boehringer
Earlier on Thursday, Drugmakers Boehringer Ingelheim and Eli Lilly and Co. announced that their type 2 diabetes treatment Trajenta has
Read morelilly
Alkermes shares promoted to “Buy” by UBS analyst
In view of the fact that Alkermes Inc. experienced a decline in stock prices over the last month, the company’s
Read moreFDA approval for Lilly’s Bydureon delayed until Jan 28
Subsequent to a delay of one year for the approval of once-per-week diabetes drug Bydureon, the United States Food and
Read more